[1]章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322-324,329.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
　ZHANG Yuling,ZHOU Yue.Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features[J].,2022,51(3):322-324,329.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
点击复制

结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年3期
页码:
322-324,329
栏目:
临床研究
出版日期:
2022-03-05

文章信息/Info

Title:
Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features
作者:
章玉玲; 周 岳
(荆州市中医医院检验科,湖北 荆州 434000)
Author(s):
ZHANG Yuling; ZHOU Yue
(Department of Clinical Laboratory,Jingzhou Hospital of Traditional Chinese Medicine,Jingzhou 434000,China)
关键词:
结直肠癌;  循环肿瘤细胞;  糖类抗原24-2;  糖类抗原19-9;  临床病理特征
Keywords:
Colorectal cancer;  Circulating tumor cell;  Carbohydrate antigen 24-2;  Carbohydrate antigen 19-9;  Clinicopathological feature
分类号:
R 735.34
DOI:
DOI:10.3969/j.issn.1000-7377.2022.03.013
文献标志码:
A
摘要:
目的:检测结直肠癌患者血清循环肿瘤细胞(CTC)、糖类抗原24-2(CA242)和糖类抗原19-9(CA199)水平,探讨它们与直肠癌患者不同临床病理特征的关系。方法:收集106例结直肠癌患者作为结直肠癌组,收集结直肠腺瘤患者100例作为结直肠腺瘤组,收集同期健康体检者100例作为对照组。采用实时荧光定量聚合酶链反应(qRT-PCR)检测CTC水平。采用全自动免疫分析仪检测CA242和CA199水平。比较三组研究对象CTC、CA242、CA199水平。比较不同临床病理特征结直肠癌患者CTC、CA242、CA199水平。分析CTC、CA242、CA199与结直肠癌患者不同临床病理特征的相关性。结果:结直肠癌组和结直肠腺瘤组患者CTC、CA242、CA199水平明显高于对照组,且结直肠癌组CTC、CA242、CA199水平明显高于结直肠腺瘤组(均P<0.05)。CTC、CA242、CA199水平在TNM分期为Ⅲ-Ⅳ期、分化程度为低分化、有淋巴结转移和肝转移的结直肠癌患者中明显升高(均P<0.05)。Spearman相关性分析结果显示,CTC、CA242、CA199水平与TNM分期、分化程度、淋巴结转移、肝转移密切相关(均P<0.05)。结论:CTC、CA242、CA199水平在结直肠癌患者中明显升高,且与结直肠癌患者临床病理特征密切相关。
Abstract:
Objective:To detect the levels of circulating tumor cell(CTC),carbohydrate antigen 24-2(CA242)and carbohydrate antigen 19-9(CA199)in serum of patients with colorectal cancer,and to explore their relationship with different clinicopathological features of patients with colorectal cancer.Methods:106 patients with colorectal cancer were collected as colorectal cancer group,100 patients with colorectal adenoma as colorectal adenoma group,and 100 healthy people in the same period as control group.The level of CTC was detected by qRT-PCR.The levels of CA242 and CA199 were detected by automatic immune analyzer.The levels of CTC,CA242 and CA199 in the three groups were compared.The levels of CTC,CA242 and CA199 in patients with colorectal cancer with different clinicopathological features were compared.The correlation between CTC,CA242,CA199 and different clinicopathological features of patients with colorectal cancer was analyzed.Results:The levels of CTC,CA242 and CA199 in colorectal cancer group and colorectal adenoma group were significantly higher than those in the control group,and the levels of CTC,CA242 and CA199 in colorectal cancer group were significantly higher than those in colorectal adenoma group(all P<0.05).The levels of CTC,CA242 and CA199 were significantly increased in colorectal cancer patients with TNM stage Ⅲ-Ⅳ,low differentiation,lymph node metastasis and liver metastasis(all P<0.05).Spearman correlation analysis showed that the levels of CTC,CA242 and CA199 were closely related to TNM stage,differentiation,lymph node metastasis and liver metastasis(all P<0.05).Conclusion:The levels of CTC,CA242 and CA199 are significantly increased in patients with colorectal cancer,and are closely related to the clinicopathological features.

参考文献/References:

[1] 朱公建,朱奕潼,丁高恒,等.2009—2015年甘肃省肿瘤登记地区结直肠癌流性特征及变化趋势分析[J].实用肿瘤学杂志,2021,35(3):212-217.
[2] 叶显辉,汪秀云.晚期结直肠癌化疗后复发转移的影响因素分析[J].实用癌症杂志,2020,35(2):330-334.
[3] 卢梅梅,张海燕,谭婧宇,等.延续护理模式对结直肠癌高危人群结直肠镜筛查依从性的影响[J].重庆医科大学学报,2020,45(10):1501-1505.
[4] 张 姣,陈志仁,梁 妍,等.PET-MRI检查技术在结直肠癌诊断中的应用进展[J].中国实验诊断学,2021,25(1):134-136.
[5] 谢礼锋,陈鸿源,许 超,等.循环肿瘤细胞在结直肠癌临床诊疗中的应用[J].福建医科大学学报,2019,53(1):66-70.
[6] 邹超世,林 英,刘康海,等.多种肿瘤标志物联合检测诊断结直肠癌的临床价值及预后监测研究[J].国际检验医学杂志,2018,39(23):2960-2963.
[7] 中华人民共和国国家卫生健康委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2020年版)[J].中国实用外科杂志,2020,40(6):601-625.
[8] 王德征,张 爽,张 辉,等.天津市结直肠癌死亡率1999—2015年变化趋势分析[J].中华胃肠外科杂志,2019,22(6):579-586.
[9] 乔喜婷,邱春丽,肖海娟,等.益气通腑汤预防结直肠癌根治术后复发转移疗效研究[J].陕西中医,2019,40(11):1513-1515.
[10] 张筱东,谢星星,张正祥,等.胃癌循环肿瘤细胞膜滤过分离技术检测及其与临床病理特征关系研究[J].陕西医学杂志,2020,49(12):1684-1687.
[11] 张 月,韩振国.循环肿瘤细胞在结直肠癌方面的研究进展[J].中国医药导报,2019,16(22):62-65.
[12] 侯洁心,郭 萍.免疫组化标志物Her-2和肿瘤标志物在胃癌诊断中的价值分析[J].陕西医学杂志,2019,48(1):121-124.
[13] 杨 娟,李亚飞,宋晓燕,等.血清CA72-4、CA19-9对结直肠癌的诊断价值及与肿瘤进展的关系研究[J].现代生物医学进展,2020,20(24):4743-4746.
[14] 王奇龙,陈南征,吕铁升.血清CEA、CA19-9、CA24-2对结直肠癌转移及预后的评估价值[J].解放军医药杂志,2020,32(6):29-33.
[15] 李 季,沈 艳,姜 研.CT仿真结肠镜联合肿瘤标志物检测在结直肠癌中的诊断价值[J].医学综述,2021,27(5):1032-1036.
[16] 徐飞鹏,王妃凤,宏小翠,等.循环肿瘤细胞在结直肠癌患者外周血中的表达及其临床意义[J].中华实验外科杂志,2021,38(4):718-720.
[17] 赛亚飞,高美丽,金发光,等.血清肿瘤标志物CEA、CA125、CYFRA21-1在支气管肺癌诊断、病理类型及TNM分期中的价值分析[J].中华肺部疾病杂志:电子版,2019,12(1):34-37.
[18] Shao P,Sun D,Wang L,et al.Deep sequencing and comprehensive expression analysis identifies several molecules potentially related to human poorly differentiated hepatocellular carcinoma[J].Febs Open Bio,2017,7(11):1696-1706.
[19] 付 裕,鲁稳柱,李鸿鹏.结直肠癌术后血清CTCs、CA125、CEA及CA19-9水平与复发或转移的相关性研究[J].中国煤炭工业医学杂志,2020,23(2):143-148.
[20] 潘莉娟,杨 静,董 剑,等.术前血清CEA、CA19-9、CA50、AFP、TPS检测在结直肠癌肝转移中的预测价值[J].国际检验医学杂志,2020,41(8):923-926.

相似文献/References:

[1]柯东平,毛俊倩,刘 琪,等.TRIM21调控人结直肠癌细胞增殖分子机制研究*[J].陕西医学杂志,2019,(6):691.
　KE Dongping,MAO Junqian,LIU Qi,et al.Study on molecular mechanisms of TRIM21 in regulating proliferation of colorectal cancer[J].,2019,(3):691.
[2]张 慧,陈景志,陈建立△,等.DCC和MKK4基因在结直肠癌组织中的表达及临床意义*[J].陕西医学杂志,2019,(8):968.
　ZHANG Hui,CHEN Jingzhi,CHEN Jianli,et al.Expression and clinical significance of DDC and MKK4 genes in colorectal cancer tissue[J].,2019,(3):968.
[3]高怀军,余 伟.腹腔镜结直肠癌根治术治疗结直肠癌临床疗效及对患者胃肠功能的影响[J].陕西医学杂志,2019,(8):990.
　GAO Huaijun,YU Wei..Clinical study of laparoscopic radical resection in the treatment of colorectal cancer in and its influence on gastrointestinal function[J].,2019,(3):990.
[4]李 虎,杨 翔,冯凯勋,等.循环肿瘤细胞检测对宫颈癌患者预后的判断价值[J].陕西医学杂志,2021,50(4):492.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.029]
[5]赵英旋,白玉勤.结直肠癌患者肿瘤出芽情况与临床病理特征、程序性死亡受体1及程序性死亡配体1表达相关性研究[J].陕西医学杂志,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
　ZHAO Yingxuan,BAI Yuqin.Correlation between tumor budding and clinicopathological characteristics,expression of PD-1 and PD-L1 in CRC[J].,2021,50(3):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
[6]马 骞,朱 军,蔡梦珊,等.基于exoRBase外泌体数据库结直肠癌竞争性内源RNA网络构建及富集分析[J].陕西医学杂志,2021,50(7):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
　MA Qian,ZHU Jun,CAI Mengshan,et al.Construction and enrichment analysis of competing endogenous RNA network for colorectal cancer based on the exoRBase database[J].,2021,50(3):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
[7]张利伟,胡海燕.粪便硫酸类肝素蛋白多糖2与分泌型卷曲相关蛋白2基因甲基化检测在结直肠癌筛查中的应用价值[J].陕西医学杂志,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
　ZHANG Liwei,HU Haiyan.Application value of feces detection of syndecan-2 and secreted frizzled related protein 2 gene methylation in colorectal cancer screening[J].,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
[8]曹巍巍,郭修田.结直肠癌原位移植造模技术研究进展[J].陕西医学杂志,2022,51(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
　CAO Weiwei,GUO Xiutian.Research progress of orthotopic transplantation technology for colorectal cancer[J].,2022,51(3):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
[9]张言言,韩 刚,曹 羽,等.同源盒基因10调控胰岛素样生长因子结合蛋白3与肠癌细胞5-氟尿嘧啶抵抗的关系研究[J].陕西医学杂志,2022,51(7):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
　ZHANG Yanyan,HAN Gang,CAO Yu,et al.Relationship between regulation of IGFBP3 by HOXD10 and 5-fluorouracil resistance in colorectal cancer cells[J].,2022,51(3):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
[10]张晓峰,冯 景,季飞燕,等.结直肠癌术后辅助化疗患者肠内营养不耐受影响因素及小野寺预后营养指数预测价值分析[J].陕西医学杂志,2022,51(9):1114.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.016]

备注/Memo

备注/Memo:
基金项目:湖北省卫生健康委员会科研课题(WJ2019F164)
更新日期/Last Update: 2022-03-04